The Department of Biomedical Engineering (BME) is committed to investigation, innovation, and translation of scientific discoveries to enhance patient care.
The Department of Biomedical Engineering, formed in 1991 by the amalgamation of the former Departments of Artificial Organs and Musculoskeletal Research, is the largest of eleven highly interactive departments in the Lerner Research Institute of the Cleveland Clinic. The department occupies more than 80,000 sq. ft. (7,500 sq. m.) and consists of more than 200 individuals, approximately 70 of whom hold a Ph.D., M.D., or dual Ph.D.-M.D. degrees. Other department personnel include research engineers and technicians, administrative assistants, manuscript/grant and editorial assistants, a quality control engineer, and more than 40 graduate students.
The department enjoys proven success and has obtained more than $27 million in federal and state grant funding in 2010-2011. It is the leading department in innovation, as determined by the number of invention disclosures filed and patents issued naming BME personnel. Through its close ties with Cleveland Clinic Innovations, BME translates many of its technologies into the clinical arena.
Biomedical Engineering Research Offers Hope to Heart Failure Patients
By Leonard Golding, MBBS, FRACS
Over 23 million patients suffer from heart failure each year, leaving 100,000 with no other option but a heart transplant. Unfortunately, due to a shortage of donors, one quarter of those patients will die waiting for a heart. While artificial hearts can reduce the need for donor hearts, the existing FDA-approved devices are complex, bulky, and able to fit in only 20 percent of women and 50 percent of men. Researchers at the Lerner Research Institute have developed a smaller artificial heart that fits most adults and many teens and is more efficient than other hearts on the market. The continuous flow total artificial heart (TAH), comprising both an artificial heart and left ventricular assist device, operates with only a single moving part and smoothly and silently pumps six liters of fluid per minute (most people do well with four to five liters per minute).
The elegant, magnetic design was developed by Leonard Golding, MBBS, a former heart surgeon, and David Horvath, a research engineer, both of the Lerner Research Institute’s Department of Biomedical Engineering. The TAH device is designed for long-term, durable use in patients suffering from biventricular heart failure. “This is an outstanding breakthrough,” Golding said. "The goal is not a bridge to a transplant, but a permanent device."
A Korean private-equity group called Power Heart recently invested $30 million to fund development and clinical trials for the TAH. The biotech company Cleveland Heart, a joint venture between Cleveland Clinic and TransWorld Medical Devices, will hold international clinical trials, expand laboratory research, and implement new design concepts.
Pilot BME Program Encourages Intercontinental Education: ‘Okaeshi’ – BME Visitors Make a Return Visit to Japan
An academic and personal collaboration of more than 30 years has helped bring forth an education program in Biomedical Engineering that could expand to the entire Lerner Research Institute.The young program encourages Japanese students from Mie University to do a 6-month "rotation" in BME laboratories.
Biomedical Engineering Research Offers Hope to Heart Failure Patients
Researchers at the Lerner Research Institute have developed a smaller artificial heart that fits most adults and many teens and is more efficient than other hearts on the market. The continuous flow total artificial heart (TAH), comprising both an artificial heart and left ventricular assist device, operates with only a single moving part and smoothly and silently pumps six liters of fluid per minute (most people do well with four to five liters per minute).
Friday, 24 May 2013 | NE1-205 | Seminar Cancelled
Seminar Cancelled